Sublimed   Report issue

For profit
Founded: Grenoble France (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2018
NCT03902340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Sublimed